The Justice Department (DOJ) has rescheduled certain marijuana products, signaling a notable policy shift after decades of strict federal control. Acting AG Todd Blanche announced that cannabis products approved by the FDA or authorized under state medical cannabis programs will be moved from Schedule I to Schedule III.
It remains to be seen whether this recent policy change will have tangible benefits to companies like Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) or broader reforms are the only way to ease…
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]
CannabisNewsWire is powered by IBN